Sun Strikes Deal For Clascoterone In US And Canada
Enters Into License And Supply Agreement With Italy’s Cassiopea For Winlevi
Sun Pharma has expanded its dermatology portfolio by entering into a partnership with Italy’ Cassiopea to market Winlevi (clascoterone) 1% cream in the US and Canada, and expects to make it available in the US inthe fourth quarter of 2021.
